Amarin Corp Plc (AMRN)

[HDGabor]

P-

pharmacy could do a generic switch without physician’s approval and patient getting worthless fake substitute without physician knowing until follow-up visit

My understanding of the method: pharmacy could do a generic switch without physician’s approval and patient getting worthless fake substitute WITHOUT coverage, aka for (e.g.) $200+ / script ... I do not think it is a threat.

Best,
G

ps.:

worthless fake

What is the basis of this? (Top of your emotion.)